Post by Arina Cadariu MD MPH

"People living today, they are not thinking about what's going to happen to them tomorrow or next week." Michael E. DeBakey, Academy of Achievement interview (Class of 1967) The Surgeon on the Table On New Year's Eve 2005, a ninety-seven-year-old man sat alone in his study in Houston preparing a lecture when a pain tore through his chest, moved between his shoulder blades, and shot into his neck. He knew exactly what it was, because he had spent his life treating it and the classification system for it carries his name. Michael DeBakey had performed the first successful repair of a dissecting aortic aneurysm on July 7, 1954, alongside Denton Cooley and Oscar Creech, and had sewn the first Dacron aortic graft on his wife's sewing machine. Now his own aorta had torn. Months later he was saved by the operation he invented, becoming the oldest person to survive it. "It is a miracle," he told the New York Times. "I really should not be here." The reason his story is famous is that almost no one else gets that ending. A ruptured aortic aneurysm kills as many as eight or nine in ten, and many are dead before they reach a hospital. It is one of the hardest diagnoses in medicine to make in time, because the aorta gives so little warning. Palpation of the belly finds fewer than a third of small aneurysms and only about three-quarters of the large ones. Up to a third of ruptures are misdiagnosed on first contact. Only a quarter of patients arrive with the textbook triad of pain, low pressure, and a pulsatile mass. The exam that is supposed to catch it mostly doesn't. So who should we screen? The evidence points to one clear group. The U.S. Preventive Services Task Force recommends a single ultrasound, one time, for men aged sixty-five to seventy-five who have ever smoked, the population where the disease is common enough and the test good enough that finding it saves lives. Ultrasound is about ninety-five percent sensitive and nearly one hundred percent specific, painless, radiation-free, and cheap. For a man who fits that box, it is close to the highest-yield fifteen minutes in preventive medicine. The trouble is everyone outside the box. The disease also takes men who never smoked, women, the hypertensive, the ones carrying a connective-tissue trait they never knew about, and the ones now dropping weight fast on a prescription. None of them sit inside the single group the guideline draws. For them there is no screening program at all, only the palpating hand that misses most of what it reaches for. If the man who built the operation nearly didn't make it to the table, what are the odds for the patient who was never screened at all? And are there any reasons we should change the guidelines in 2026? Subscribe here : https://lnkd.in/edsg4edv #healthincontext #screening #aorticdissection #sarcopenia #malnutrition #weightloss #risk #Ozempic #Semaglutide #Tirzepatide #WeightLoss #Obesity